- Advanced search
|International Nonproprietary Names|
|Search PubMed clinical trials||eldelumab|
|Search PubMed titles||eldelumab|
|Search PubMed titles/abstracts||eldelumab|
|Eldelumab (BMS-936557 and formerly MDX-1100) is a a fully human monoclonal antibody targeting the chemokine CXCL10 (a.k.a. interferon-γ-inducible protein-10 or IP-10) . It is being investigated for its anti-inflammatory action in autoimmune conditions.
BLAST peptide sequence analysis reveals exact matches with heavy and light chain variable regions claimed in patent US8258266, and identify eldelumab as clone 6A5 .